Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The British Journal of Psychiatry. Supplement
|
September 26, 2002
Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors
A P Morrison, R P Bentall, P French, et al.
Schizophrenia Research
|
May 1, 1996
Do obstetric complications cause the earlier age at onset in male than female schizophrenics?
G Kirov, P B Jones, I Harvey, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 18, 2013
Improved quality of life over one year is associated with improved adherence in patients with schizophrenia
K P Hayhurst, R J Drake, J A Massie, et al.
Psychopharmacology
|
July 8, 2003
Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies
V S Gabrovska-Johnson, M Scott, S Jeffries, et al.
Acta Psychiatrica Scandinavica
|
August 18, 2010
Experience sampling research in individuals with mental illness: reflections and guidance
J E Palmier-Claus, I Myin-Germeys, E Barkus, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1993
Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study
P B Jones, P Bebbington, A Foerster, et al.
Schizophrenia Research
|
March 1, 1996
Family history of autoimmune diseases in psychosis
C M Gilvarry, P C Sham, P B Jones, et al.
Psychological Medicine
|
May 4, 2017
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial
J Lees, P G Michalopoulou, S W Lewis, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
S W Lewis, L Davies, P B Jones, et al.
Lancet (London, England)
|
May 21, 1999
Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm
A L Stewart, L Rifkin, P N Amess, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The British Journal of Psychiatry. Supplement
|
September 26, 2002
Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors
A P Morrison, R P Bentall, P French, et al.
Schizophrenia Research
|
May 1, 1996
Do obstetric complications cause the earlier age at onset in male than female schizophrenics?
G Kirov, P B Jones, I Harvey, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 18, 2013
Improved quality of life over one year is associated with improved adherence in patients with schizophrenia
K P Hayhurst, R J Drake, J A Massie, et al.
Psychopharmacology
|
July 8, 2003
Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies
V S Gabrovska-Johnson, M Scott, S Jeffries, et al.
Acta Psychiatrica Scandinavica
|
August 18, 2010
Experience sampling research in individuals with mental illness: reflections and guidance
J E Palmier-Claus, I Myin-Germeys, E Barkus, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 1, 1993
Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study
P B Jones, P Bebbington, A Foerster, et al.
Schizophrenia Research
|
March 1, 1996
Family history of autoimmune diseases in psychosis
C M Gilvarry, P C Sham, P B Jones, et al.
Psychological Medicine
|
May 4, 2017
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial
J Lees, P G Michalopoulou, S W Lewis, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2006
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
S W Lewis, L Davies, P B Jones, et al.
Lancet (London, England)
|
May 21, 1999
Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm
A L Stewart, L Rifkin, P N Amess, et al.
Page
of 10